Timothy Olson MD Ph.D.
Assistant Professor of Pediatrics Children's Hospital of Philadelphia University of Pennsylvania
Join to View Full Profile
3401 Civic Center Blvd# ChildrenPhiladelphia, PA 19104
Phone+1 215-590-3535
Fax+1 215-590-3992
Dr. Olson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2008 - 2012- Children's Hospital of PhiladelphiaResidency, Pediatrics, 2006 - 2008
University of Virginia School of MedicineClass of 2006
Certifications & Licensure
DE State Medical License Current
PA State Medical License 2006 - 2026
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Fludarabine Based RIC for Bone Marrow Failure Syndromes
- Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors Start of enrollment: 2019 Apr 03
Roles: Principal Investigator, Contact
- A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202) Start of enrollment: 2023 Jan 25
Roles: Contact
Publications & Presentations
PubMed
- Diagnosis and Management of Prenatal Hereditary Pyropoikilocytosis.Connor Hartzell, Samantha Stover, Nora Gibson, Timothy Olson, James Connelly
Prenatal Diagnosis. 2025-07-26 - Outcomes of Unrelated Donor Stem Cell Transplantation with Partial T Cell Depletion for Pediatric Patients with Hemoglobinopathies.Nora M Gibson, Caitlin W Elgarten, Joseph H Oved, Lisa Wray, Jason Freedman
Transplantation and Cellular Therapy. 2025-07-01 - 2 citationsImpact of HLA alloimmunization in gene-modified autologous stem cell transplant for transfusion-dependent thalassemia.Nora M Gibson, Eugene Khandros, Caitlin W Elgarten, Elizabeth Worster, Dimitrios S Monos
Blood. 2025-05-29
Journal Articles
- Germline Duplication of ATG2B and GSKIP Genes Is Not Required for the Familial Myeloid Malignancy Syndrome Associated with the Duplication of Chromosome 14q32David B Lieberman, Daria V Babushok, Timothy S Olson, Stella T Chou, Elizabeth O Hexner, Nature
Press Mentions
First Patient to Receive Gene Therapy ‘Cure’ for Beta-Thalassemia Living Pain-FreeMay 5th, 2025
Turn Biotechnologies Announces Landmark Study to Assess Effectiveness of ERA™ Therapy in Restoring Bone Marrow USA - English USA - Français USA - Nederlands Japan - Japanese Korea - 한국어 APAC - English USA - DeutschDecember 3rd, 2024
Turn Biotechnologies Announces Landmark Study to Assess Effectiveness of ERA™ Therapy in Restoring Bone MarrowDecember 3rd, 2024- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
